AXA/2025/FY financial supplement: Difference between revisions

Content deleted Content added
PlumBot: publish from draft
 
PlumBot: publish from draft
 
Line 17:
<div style="overflow-x:auto">
{| class="wikitable" style="width:100%"
|+ Average foreign exchange rates byfor currencymajor currencies for half-years 2024 and 2025 and fiscal years 2024 and 2025
! style="text-align:left" | —
! style="text-align:right; width:6em" | 1H24
Line 82:
<div style="overflow-x:auto">
{| class="wikitable" style="width:100%"
|+ Average interest rates byfor currencymajor currencies for half-years 2024 and 2025 and fiscal years 2024 and 2025
! style="text-align:left" | —
! style="text-align:right; width:6em" | Average 1H24
Line 129:
<div style="overflow-x:auto">
{| class="wikitable" style="width:100%"
|+ Closing interest rates byfor currencymajor currencies for half-years 2024 and 2025 and fiscal years 2024 and 2025
! style="text-align:left" | —
! style="text-align:right; width:6em" | Closing 1H24
Line 178:
<div style="overflow-x:auto">
{| class="wikitable" style="width:100%"
|+ Underlying earnings (UE) breakdown by line of business (LOB) and net income for half-years 2024 and 2025 and fiscal years 2024 and 2025
! style="text-align:left" | EUR million
! colspan="4" style="text-align:center" | Group
Line 833:
<div style="overflow-x:auto">
{| class="wikitable" style="width:100%"
|+ Underlying earnings (UE) breakdown by geography for half-years 2024 and 2025 and fiscal years 2024 and 2025
! style="text-align:left" | EUR million
! colspan="4" style="text-align:center" | Group
Line 1,549:
<div style="overflow-x:auto">
{| class="wikitable" style="width:100%"
|+ Property & casualty (P&C) underlying earnings (UE) breakdown by sub-line of business (LOB) for half-years 2024 and 2025 and fiscal years 2024 and 2025
! style="text-align:left" | EUR million
! colspan="4" style="text-align:center" | Total
Line 2,151:
| style="text-align:right" | —
|-
| style="text-align:left; padding-left:1.5em" | Oo/w VFA
| style="text-align:right" | 0
| style="text-align:right" | 0
Line 2,173:
| style="text-align:right" | —
|-
| style="text-align:left; padding-left:1.5em" | Oo/w non VFA
| style="text-align:right" | 113,515
| style="text-align:right" | 118,104
Line 2,270:
<div style="overflow-x:auto">
{| class="wikitable" style="width:100%"
|+ Property & casualty (P&C) underlying earnings (UE) breakdown by geography for half-years 2024 and 2025 and fiscal years 2024 and 2025
! style="text-align:left" | EUR million
! colspan="4" style="text-align:center" | Total
Line 2,276:
! colspan="4" style="text-align:center" | Europe
! style="text-align:center" | AXA XL
! style="text-align:center" | Oo/w AXA XL insurance
! style="text-align:center" | FY24
! style="text-align:center" | Oo/w AXA XL insurance
! style="text-align:center" | AXA XL1H25
! style="text-align:center" | Oo/w AXA XL insurance
! style="text-align:center" | FY25
! style="text-align:center" | Oo/w AXA XL insurance
! colspan="4" style="text-align:center" | Asia, Africa & EME-LATAM
! colspan="4" style="text-align:center" | Transversal & other
Line 2,300:
! style="text-align:right; width:6em" | FY25
! style="text-align:right; width:6em" | 1H24
! style="text-align:right; width:6em" | o/w AXA XL insurance
! style="text-align:right; width:6em" | FY24
! style="text-align:right; width:6em" | o/w AXA XL insurance
! style="text-align:right; width:6em" | 1H25
! style="text-align:right; width:6em" | o/w AXA XL insurance
! style="text-align:right; width:6em" | FY25
! style="text-align:right; width:6em" | o/w AXA XL insurance
! style="text-align:right; width:6em" | 1H24
! style="text-align:right; width:6em" | FY24
Line 3,810:
<div style="overflow-x:auto">
{| class="wikitable" style="width:100%"
|+ UnderlyingLife and health underlying earnings (UE) breakdown by geography for life and health for 1H24, FY24, 1H25, and FY25
! style="text-align:left" | EUR million
! colspan="4" style="text-align:center" | Total
Line 4,657:
<div style="overflow-x:auto">
{| class="wikitable" style="width:100%"
|+ UnderlyingLife underlying earnings (UE) breakdown by geography for life for 1H24, FY24, 1H25, and FY25
! style="text-align:left" | EUR million
! colspan="4" style="text-align:center" | Total
Line 5,504:
<div style="overflow-x:auto">
{| class="wikitable" style="width:100%"
|+ UnderlyingHealth underlying earnings (UE) breakdown by geography for health for 1H24, FY24, 1H25, and FY25
! style="text-align:left" | EUR million
! colspan="4" style="text-align:center" | Total
Line 6,351:
<div style="overflow-x:auto">
{| class="wikitable" style="width:100%"
|+ Asset management rollforward by asset under management (AUM) and underlying earnings (UE) for 1H24, FY24, 1H25, and FY25
! style="text-align:left" | EUR million
! colspan="2" style="text-align:center" | 1H24
Line 6,368:
! style="text-align:right; width:6em" | o/w third party
|-
| style="text-align:left" | '''Opening AUM (in euroEUR billion)'''
| style="text-align:right" | '''843'''
| style="text-align:right" | '''332'''
Line 6,418:
| style="text-align:right" | -6
|-
| style="text-align:left" | '''Closing AUM (in euroEUR billion)'''
| style="text-align:right" | '''859'''
| style="text-align:right" | '''340'''
Line 6,636:
<div style="overflow-x:auto">
{| class="wikitable" style="width:100%"
|+ UnderlyingHoldings underlying earnings (UE) for holdings for 1H24, FY24, 1H25, and FY25
! style="text-align:left" | EUR million
! style="text-align:right; width:6em" | 1H24
Line 6,704:
* <sup>⁴</sup> On top of annual share buy-back, includes Euro +3.5 billion share buy-back in 2025 to offset the earnings dilution resulting from the disposal of AXA IM and Euro +0.7 billion share buy-back in 2024 from the reinsurance treaties for the in-force Savings portfolio at AXA France (Euro +0.5 billion) and AXA Life Europe (Euro +0.2 billion).
 
== 13. Activity indicatorsIndicators ==
 
<div style="overflow-x:auto">
{| class="wikitable" style="width:100%"
|+ Activity indicators breakdown by segment for 1H24, FY24, 1H25, and FY25
! style="text-align:left" | EUR million
! style="text-align:center" | Total
! style="text-align:center" | P&C
! style="text-align:center" | Life & health
! style="text-align:center" | o/w employee benefits
! style="text-align:center" | Life
! style="text-align:center" | Health
! style="text-align:center" | Asset management
! style="text-align:center" | Bank
! style="text-align:center" | Total
! style="text-align:center" | P&C
! style="text-align:center" | Life & health
! style="text-align:center" | o/w employee benefits
! style="text-align:center" | Life
! style="text-align:center" | Health
! style="text-align:center" | Asset management
! style="text-align:center" | Bank
! style="text-align:center" | Total
! style="text-align:center" | P&C
! style="text-align:center" | Life & health
! style="text-align:center" | o/w employee benefits
! style="text-align:center" | Life
! style="text-align:center" | Health
! style="text-align:center" | Asset management
! style="text-align:center" | Bank
! style="text-align:center" | Total
! style="text-align:center" | P&C
! style="text-align:center" | Life & health
! style="text-align:center" | o/w employee benefits
! style="text-align:center" | Life
! style="text-align:center" | Health
! style="text-align:center" | Asset management
! style="text-align:center" | Bank
|-
! style="text-align:left" | —
! colspan="8" style="text-align:center" | 1H24
! colspan="8" style="text-align:center" | FY24
! colspan="8" style="text-align:center" | 1H25
! colspan="8" style="text-align:center" | FY25
|-
! style="text-align:left" | —
! style="text-align:right; width:6em" | Total
! style="text-align:right; width:6em" | P&C
! style="text-align:right; width:6em" | Life & health
! style="text-align:right; width:6em" | o/w employee benefits
! style="text-align:right; width:6em" | Life
! style="text-align:right; width:6em" | Health
! style="text-align:right; width:6em" | Asset management
! style="text-align:right; width:6em" | Bank
! style="text-align:right; width:6em" | Total
! style="text-align:right; width:6em" | P&C
! style="text-align:right; width:6em" | Life & health
! style="text-align:right; width:6em" | o/w employee benefits
! style="text-align:right; width:6em" | Life
! style="text-align:right; width:6em" | Health
! style="text-align:right; width:6em" | Asset management
! style="text-align:right; width:6em" | Bank
! style="text-align:right; width:6em" | Total
! style="text-align:right; width:6em" | P&C
! style="text-align:right; width:6em" | Life & health
! style="text-align:right; width:6em" | o/w employee benefits
! style="text-align:right; width:6em" | Life
! style="text-align:right; width:6em" | Health
! style="text-align:right; width:6em" | Asset management
! style="text-align:right; width:6em" | Bank
! style="text-align:right; width:6em" | Total
! style="text-align:right; width:6em" | P&C
! style="text-align:right; width:6em" | Life & health
! style="text-align:right; width:6em" | o/w employee benefits
! style="text-align:right; width:6em" | Life
! style="text-align:right; width:6em" | Health
! style="text-align:right; width:6em" | Asset management
! style="text-align:right; width:6em" | Bank
|-
| style="text-align:left" | Gross written premiums & other revenues
Line 6,991:
<div style="overflow-x:auto">
{| class="wikitable" style="width:100%"
|+ Activity indicators breakdown by geography for 1H24, FY24, 1H25, and FY25
! style="text-align:left" | EUR million
! style="text-align:center" | Total
! style="text-align:center" | France
! style="text-align:center" | Europe
! style="text-align:center" | AXA XL
! style="text-align:center" | Asia, Africa & EME-LATAM
! style="text-align:center" | AXA IM
! style="text-align:center" | Transversal & other
! style="text-align:center" | Total
! style="text-align:center" | France
! style="text-align:center" | Europe
! style="text-align:center" | AXA XL
! style="text-align:center" | Asia, Africa & EME-LATAM
! style="text-align:center" | AXA IM
! style="text-align:center" | Transversal & other
! style="text-align:center" | Total
! style="text-align:center" | France
! style="text-align:center" | Europe
! style="text-align:center" | AXA XL
! style="text-align:center" | Asia, Africa & EME-LATAM
! style="text-align:center" | AXA IM
! style="text-align:center" | Transversal & other
! style="text-align:center" | Total
! style="text-align:center" | France
! style="text-align:center" | Europe
! style="text-align:center" | AXA XL
! style="text-align:center" | Asia, Africa & EME-LATAM
! style="text-align:center" | AXA IM
! style="text-align:center" | Transversal & other
|-
! style="text-align:left" | —
! colspan="7" style="text-align:center" | 1H24
! colspan="7" style="text-align:center" | FY24
! colspan="7" style="text-align:center" | 1H25
! colspan="7" style="text-align:center" | FY25
|-
! style="text-align:left" | —
! style="text-align:right; width:6em" | Total
! style="text-align:right; width:6em" | France
! style="text-align:right; width:6em" | Europe
! style="text-align:right; width:6em" | AXA XL
! style="text-align:right; width:6em" | Asia, Africa & EME-LATAM
! style="text-align:right; width:6em" | AXA IM
! style="text-align:right; width:6em" | Transversal & other
! style="text-align:right; width:6em" | Total
! style="text-align:right; width:6em" | France
! style="text-align:right; width:6em" | Europe
! style="text-align:right; width:6em" | AXA XL
! style="text-align:right; width:6em" | Asia, Africa & EME-LATAM
! style="text-align:right; width:6em" | AXA IM
! style="text-align:right; width:6em" | Transversal & other
! style="text-align:right; width:6em" | Total
! style="text-align:right; width:6em" | France
! style="text-align:right; width:6em" | Europe
! style="text-align:right; width:6em" | AXA XL
! style="text-align:right; width:6em" | Asia, Africa & EME-LATAM
! style="text-align:right; width:6em" | AXA IM
! style="text-align:right; width:6em" | Transversal & other
! style="text-align:right; width:6em" | Total
! style="text-align:right; width:6em" | France
! style="text-align:right; width:6em" | Europe
! style="text-align:right; width:6em" | AXA XL
! style="text-align:right; width:6em" | Asia, Africa & EME-LATAM
! style="text-align:right; width:6em" | AXA IM
! style="text-align:right; width:6em" | Transversal & other
|-
| style="text-align:left" | Gross written premiums & other revenues
Line 7,247:
<div style="overflow-x:auto">
{| class="wikitable" style="width:100%"
|+ Balance sheet assets breakdown for fiscal years 2024 and 2025
! style="text-align:left" | EUR billion
! style="text-align:right; width:6em" | FY24
Line 7,324:
<div style="overflow-x:auto">
{| class="wikitable" style="width:100%"
|+ Balance sheet liabilities, non-controlling interests and equityshareholders' breakdownequity for fiscal years 2024 and 2025
! style="text-align:left" | EUR billion
! style="text-align:right; width:6em" | FY24
Line 7,391:
</div>
 
== 15. CSM Rollforwardrollforward ==
 
<div style="overflow-x:auto">
{| class="wikitable" style="width:100%"
|+ Contractual service margin (CSM) rollforward by segment, pre-tax and post-tax, for fiscal year 2024
! style="text-align:left" | EUR million
! style="text-align:right; width:6em" | FY23 restated
Line 7,462:
<div style="overflow-x:auto">
{| class="wikitable" style="width:100%"
|+ Contractual service margin (CSM) rollforward by segment, pre-tax and post-tax, for fiscal year 2025
! style="text-align:left" | EUR million
! style="text-align:right; width:6em" | FY24
Line 7,613:
<div style="overflow-x:auto">
{| class="wikitable" style="width:100%"
|+ Fair value by rating breakdown of invested assets
! style="text-align:left" | EUR billion
! colspan="7" style="text-align:center" | Fair value by rating
Line 8,086:
</div>
 
== 19. ROERoE & Gearing ==
 
<div style="overflow-x:auto">
{| class="wikitable" style="width:100%"
|+ ROEReturn andon underlyingequity (ROE) analysis for fiscal years 2024 and 2025
! style="text-align:left" | EUR billion
! style="text-align:right; width:6em" | FY24
Line 8,134:
<div style="overflow-x:auto">
{| class="wikitable" style="width:100%"
|+ Debt gearing and shareholders' equity build-up for fiscal years 2024 and 2025
! style="text-align:left" | EUR billion
! style="text-align:right; width:6em" | FY24
Line 8,199:
<div style="overflow-x:auto">
{| class="wikitable" style="width:100%"
|+ Solvency II eligible own funds (EOF), solvency capital requirement (SCR), and solvency II ratio rollforward for fiscal years 2024 and 2025
! style="text-align:left" | EUR billion
! style="text-align:right; width:6em" | FY24
Line 8,248:
<div style="overflow-x:auto">
{| class="wikitable" style="width:100%"
|+ Solvency II eligibleEligible own funds (EOF) breakdown by tier and sector for fiscal years 2024 and 2025
! style="text-align:left" | EUR billion
! style="text-align:right; width:6em" | Total